• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国化脓性汗腺炎的流行病学-基于多源方法的观察性队列研究。

Epidemiology of hidradenitis suppurativa in Germany - an observational cohort study based on a multisource approach.

机构信息

Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

出版信息

J Eur Acad Dermatol Venereol. 2020 Jan;34(1):174-179. doi: 10.1111/jdv.15940. Epub 2019 Oct 8.

DOI:10.1111/jdv.15940
PMID:31494987
Abstract

BACKGROUND

Hidradenitis suppurativa (HS) is a chronic, debilitating inflammatory skin disease. In Germany, there are no population-based data on the epidemiology of HS.

OBJECTIVES

The objective of this study was to examine the occurrence of HS in inpatient as well as in outpatient settings.

METHODS

We used three data sources for analysing the prevalence, incidence and case-related occurrence of HS in different settings: data of two German statutory health insurance (SHI) companies and hospital discharge data provided by the Federal Statistical Office. The studied period was from 2010 to 2015.

RESULTS

In a representative sample of about 2.3 million insurees (out of 5.9 million total persons) of the SHI DAK-Gesundheit, 791 were diagnosed with HS in 2010. This coding prevalence of 0.03% is in accordance with the data of another SHI (Barmer) on about 9 million total insurees. In 2015, at least 34.7% of incident persons with HS had one potential misdiagnosis in 2014.

CONCLUSION

This population-based study analyses the prevalence and incidence of HS in Germany. The coding prevalence of 0.03% observed in two independent SHI data sets is lower than expected. The findings of considerable potential misdiagnosis add to the underdiagnosis of HS in general and underline the need for future strategies to early detection and valid diagnosis of HS.

摘要

背景

化脓性汗腺炎(HS)是一种慢性、使人虚弱的炎症性皮肤病。在德国,尚无关于 HS 流行病学的基于人群的数据。

目的

本研究旨在检查住院和门诊环境中 HS 的发生情况。

方法

我们使用了三个数据源来分析不同环境中 HS 的患病率、发病率和与病例相关的发生情况:两家德国法定健康保险(SHI)公司的数据和联邦统计局提供的医院出院数据。研究期间为 2010 年至 2015 年。

结果

在 DAK-Gesundheit 的约 230 万参保人中(总计 590 万人)的代表性样本中,2010 年有 791 人被诊断为 HS。这种编码患病率为 0.03%,与另一家 SHI(Barmer)关于总计 900 万参保人的数据相符。2015 年,至少有 34.7%的 HS 新发病例在 2014 年存在一种潜在的误诊。

结论

本基于人群的研究分析了德国 HS 的患病率和发病率。在两个独立的 SHI 数据集观察到的 0.03%的编码患病率低于预期。存在相当多的潜在误诊的发现增加了 HS 总体上的漏诊情况,并强调了需要制定未来的策略来早期发现和有效诊断 HS。

相似文献

1
Epidemiology of hidradenitis suppurativa in Germany - an observational cohort study based on a multisource approach.德国化脓性汗腺炎的流行病学-基于多源方法的观察性队列研究。
J Eur Acad Dermatol Venereol. 2020 Jan;34(1):174-179. doi: 10.1111/jdv.15940. Epub 2019 Oct 8.
2
Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System.化脓性汗腺炎的延误诊断及其对患者和医疗保健系统的影响。
Dermatology. 2020;236(5):421-430. doi: 10.1159/000508787. Epub 2020 Jul 1.
3
Hidradenitis Suppurativa in Sweden: A Registry-Based Cross-Sectional Study of 13,538 Patients.瑞典化脓性汗腺炎:基于登记的 13538 例患者的横断面研究。
Dermatology. 2020;236(4):281-288. doi: 10.1159/000505545. Epub 2020 Feb 3.
4
Association between hidradenitis suppurativa and hospitalization for psychiatric disorders: a cross-sectional analysis of the National Inpatient Sample.化脓性汗腺炎与精神障碍住院治疗的相关性:国家住院患者样本的横断面分析。
Br J Dermatol. 2019 Aug;181(2):275-281. doi: 10.1111/bjd.17416. Epub 2019 Feb 26.
5
Diagnostic delay in Hidradenitis suppurativa investigated using data from social media and from statutory health insurances.利用社交媒体和法定医疗保险数据调查化脓性汗腺炎的诊断延迟。
J Dtsch Dermatol Ges. 2024 Jun;22(6):803-809. doi: 10.1111/ddg.15411. Epub 2024 May 20.
6
Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa.基于人群的临床实践研究数据库研究使用算法模型来确定化脓性汗腺炎的真实负担。
Br J Dermatol. 2018 Apr;178(4):917-924. doi: 10.1111/bjd.16101. Epub 2018 Feb 22.
7
Hospitalisations with Hidradenitis Suppurativa: An Increasing Problem That Deserves Closer Attention.化脓性汗腺炎导致的住院治疗:一个日益严重的问题,值得密切关注。
Dermatology. 2016;232(5):613-618. doi: 10.1159/000448515. Epub 2016 Sep 30.
8
Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States.美国化脓性汗腺炎患者 2 型糖尿病的患病率。
J Am Acad Dermatol. 2018 Jul;79(1):71-76. doi: 10.1016/j.jaad.2018.01.014. Epub 2018 Jan 12.
9
Hidradenitis Suppurativa Incidence and Prevalence Rates Are Increasing: A Population-based Study.化脓性汗腺炎发病率和流行率呈上升趋势:一项基于人群的研究。
Isr Med Assoc J. 2024 Jun;26(6):388-394.
10
Demographic and clinical features of hidradenitis suppurativa in Korea.韩国化脓性汗腺炎的人口统计学和临床特征。
J Dermatol. 2018 Dec;45(12):1389-1395. doi: 10.1111/1346-8138.14656. Epub 2018 Oct 8.

引用本文的文献

1
Identifying and Evaluating Mobile and Web Apps for Patients to Manage Hidradenitis Suppurativa: Systematic Search in App Stores and Content Analysis.识别和评估供患者管理化脓性汗腺炎的移动应用程序和网络应用程序:应用商店中的系统搜索与内容分析
JMIR Mhealth Uhealth. 2025 Aug 29;13:e69030. doi: 10.2196/69030.
2
Prevalence of Hidradenitis Suppurativa in the Netherlands: A Cross-Sectional Study as Part of the Global Hidradenitis Suppurativa Atlas (GHiSA).荷兰化脓性汗腺炎的患病率:一项作为全球化脓性汗腺炎地图集(GHiSA)一部分的横断面研究。
Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000542816.
3
Prevalence of Hidradenitis Suppurativa in the Gulf Province of Papua New Guinea.
巴布亚新几内亚海湾省化脓性汗腺炎的患病率
Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000538422.
4
Prevalence of Hidradenitis Suppurativa in Darmstadt, Germany: A Contribution to the Global Hidradenitis Suppurativa Atlas.德国达姆施塔特化脓性汗腺炎的患病率:对全球化脓性汗腺炎地图集的贡献。
Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000539285.
5
A Novel Epidermis Model Using Primary Hidradenitis Suppurativa Keratinocytes.一种使用原发性化脓性汗腺炎角质形成细胞的新型表皮模型。
J Tissue Eng Regen Med. 2024 Feb 27;2024:4363876. doi: 10.1155/2024/4363876. eCollection 2024.
6
Treatment Satisfaction in Patients with Hidradenitis Suppurativa: A Real-World Survey from the EU5 and USA.化脓性汗腺炎患者的治疗满意度:来自欧盟五国和美国的一项真实世界调查
Dermatology. 2025;241(2):149-161. doi: 10.1159/000542343. Epub 2024 Nov 5.
7
Comprehensive Codified Algorithms to Identify the Underestimated Burden of Hidradenitis Suppurativa in the United States.识别美国化脓性汗腺炎被低估负担的综合编纂算法
Dermatol Ther (Heidelb). 2024 Oct;14(10):2859-2876. doi: 10.1007/s13555-024-01259-0. Epub 2024 Sep 24.
8
Approach to the Atypical Wound.非典型创面处理方法。
Am J Clin Dermatol. 2024 Jul;25(4):559-584. doi: 10.1007/s40257-024-00865-0. Epub 2024 May 14.
9
Phenotype Algorithms to Identify Hidradenitis Suppurativa Using Real-World Data: Development and Validation Study.利用真实世界数据识别化脓性汗腺炎的表型算法:开发与验证研究
JMIR Dermatol. 2022 Nov 30;5(4):e38783. doi: 10.2196/38783.
10
Incidence, Risk Factors, and Prognosis of Hidradenitis Suppurativa Across the Globe: Insights from the Literature.全球化脓性汗腺炎的发病率、危险因素及预后:文献综述
Clin Cosmet Investig Dermatol. 2023 Mar 2;16:545-552. doi: 10.2147/CCID.S402453. eCollection 2023.